Targeting liposomes to tumor endothelial cells for neutron capture therapy
Gerben A. Koning(Università Cattolica del Sacro Cuore), Gerard C. Krijger(Erasmus MC), Urszula D. Woroniecka(Delft University of Technology), Marjan M. Fretz(Cardiff University), Gert Storm(Yong In University)
Cited by 30
Related Papers
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
|Cancer Research|2012|458
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297